Famvir

Famvir Product Description

Drug Uses

Famvir is a pro-agent, which is biotransformed into the antiviral compound penciclovir after getting into the body. Famvir tablets have a prolonged antiviral effect, and are used to control:

• Recurrent herpes forms of varying severity
• First and repeated episodes of genital herpes and shingles
• Various forms of herpes in HIV-infected patients

People suffering from herpes with or without a weakened immune system, should take one Famvir pill (150, 250 or 500 mg) every 8 or 12 hours. The average duration of anti-herpes treatment with Famvir is 7 days.

Missed dose

If the patient misses one Famvir dose, he/she should take this antiviral drug as soon as remembers. The missed Famvir pill should not be taken, if the time for taking the next dose is close. Do not double doses and do not take extra medicines to compensate for the missed dose.

More Information

Famvir-therapy should begin as soon as possible after the first signs of herpes. The maximum antiviral effect is achieved, if Famvir pills have been taken within 48-72 hours after the onset of the viral disease symptoms.

Storage

Famvir pills should be stored in a dry place in its original packaging at controlled room temperature of approximately 30°C. Keep Famvir out of reach of children and pets.

Famvir Safety Information

Warnings

High doses of Famvir can adversely affect kidney function, especially in patients with a history of this disease. The composition of Famvir tablets includes lactose, so it should not be used by people with hypersensitivity to this type of simple sugar.

Disclaimer

The information about Famvir, which is given in this report, is for information and educational purposes only, and is not intended to replace medical advice by dermatologists, gynecologists, or other specialists of infectious diseases. The online pharmacy has no control over the use of this content about Famvir, and for any direct, indirect, or other damages, arising therefrom.

Famvir Side Effects

Possible adverse reactions of the antiviral drug Famvir are mild to moderate in nature. Immunocompetent patients, who were taking Famvir to treat different types of herpes, often complained: headache, nausea, paraesthesia, dizziness, diarrhoea, fatigue, somnolence, constipation and anusitis. Confusion was observed in elderly patients taking Famvir.

In HIV-infected patients, the same adverse reactions were observed, as in immunocompetent patients. But in addition, they were reporting vomiting, abdominal pain and increased levels of creatine phosphokinase.

During the postmarketing experience, the patients treated with Famvir often complained: rash, urticaria, pruritus, delirium, disorientation, low platelet count, palpitations, and liver function worsening.